Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05112289 · ClinicalTrials.gov registry record · NA
A Study to Evaluate White Matter Hyperintensities in Migraine
A NA study of Multiple Sclerosis and Migraine, sponsored by Mayo Clinic.
- Active
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT05112289: Active NA study of Multiple Sclerosis and Migraine, sponsored by Mayo Clinic.
NCT05112289 is a NA study of Multiple Sclerosis and Migraine that is active but no longer recruiting, run by Mayo Clinic. The registered enrollment target is 50 participants, below the 585-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05112289, a NA study of Multiple Sclerosis and Migraine, is active but no longer recruiting, sponsored by Mayo Clinic.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research is to better understand brain white matter hyperintensities (WMH) in women with migraines
Primary Outcome
Radiological MRI assessment of WMH in migraine
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Brain Neuroimaging
Study Locations (1)
Arizona
- Mayo Clinic in Arizona - Phoenix
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2021-08-16 |
| Est. Completion | 2026-08 |
| Phase | NA |
What the registry record for NCT05112289 still lists
NCT05112289 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 585-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (91% lower).
The record links to 3 conditions, with Multiple Sclerosis appearing as the primary indexed condition, and to 1 intervention - of which Brain Neuroimaging is the first listed.
NCT05112289 reports a single indexed study location in Arizona.
Frequently Asked Questions
What is clinical trial NCT05112289 about?
NCT05112289 is a clinical study titled "A Study to Evaluate White Matter Hyperintensities in Migraine". The purpose of this research is to better understand brain white matter hyperintensities (WMH) in women with migraines
What is the current status of trial NCT05112289?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2021-08-16. Estimated completion is 2026-08.
What conditions does trial NCT05112289 study?
This clinical trial studies the following conditions: Multiple Sclerosis, Migraine, Small Vessel Ischemic Disease.
What interventions are being tested in trial NCT05112289?
The interventions under investigation include: Brain Neuroimaging (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05112289?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05112289 being conducted?
This trial has 1 study location across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Multiple Sclerosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05112289's enrollment target sits among peer trials
50 178th of 315 higher than 131 of 315 other Multiple Sclerosis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Multiple Sclerosis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Prepare the Mind: Can Coaching in Goal-directed Behaviour Increase the Success of Cognitive Rehabilitation in People With MS?
RECRUITING · NA
-
Incremental Vestibulo-ocular Reflex Adaptation as a Novel Treatment for Dizziness in People With Multiple Sclerosis
RECRUITING · NA
-
Intermittent Hypoxia in Persons With Multiple Sclerosis
RECRUITING · NA
-
Investigating the Effects of Wearable Robotic Exoskeleton for Improving Mobility and Cognition in Persons With MS
RECRUITING · NA
-
Central Vein Sign in Multiple Sclerosis Extension Study
RECRUITING · NA
-
Effects of Torso Weighting on Muscle Activation During Balance Tests in Individuals With and Without Multiple Sclerosis
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI